[{"NetIncomeLoss_1_Q2_USD":-55852000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":51573894.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":37034000.0,"RepaymentsOfDebtAndCapitalLeaseObligations_2_Q2_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":3766000.0,"Depreciation_2_Q2_USD":466000.0,"AssetsCurrent_0_Q2_USD":884332000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7109886.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":51644946.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2228000.0,"Assets_0_Q2_USD":997601000.0,"ShareBasedCompensation_2_Q2_USD":21012000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":70278000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-431000.0,"CommonStockSharesAuthorized_0_Q2_shares":490000000.0,"OperatingIncomeLoss_2_Q2_USD":-106467000.0,"OperatingIncomeLoss_1_Q2_USD":-55909000.0,"CommonStockSharesIssued_0_Q2_shares":51434408.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"GeneralAndAdministrativeExpense_1_Q2_USD":10505000.0,"MarketableSecuritiesCurrent_0_Q2_USD":0.0,"ResearchAndDevelopmentExpense_1_Q2_USD":45404000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-53000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-18000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-51000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-19000.0,"CommonStockValue_0_Q2_USD":5000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":3994000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":24500000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":880900000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":20726000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-106352000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-55870000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-5753000.0,"OtherAssetsNoncurrent_0_Q2_USD":27207000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":880870000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":77004000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1176948000.0,"Liabilities_0_Q2_USD":218174000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q2_USD":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":85741000.0,"InvestmentIncomeInterest_2_Q2_USD":230000.0,"PreferredStockValue_0_Q2_USD":null,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-53000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-18000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":11087000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-71286000.0,"LiabilitiesCurrent_0_Q2_USD":41020000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-63526000.0,"AccountsPayableCurrent_0_Q2_USD":2738000.0,"InterestExpense_2_Q2_USD":11000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":0.0,"InterestExpense_1_Q2_USD":5000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3462000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3711000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2433000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-35000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":887194000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":305000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":9460000.0,"NetIncomeLoss_2_Q2_USD":-106299000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":305000.0,"InvestmentIncomeInterest_1_Q2_USD":81000.0,"RestrictedCashNoncurrent_0_Q2_USD":6324000.0,"CommonStockSharesOutstanding_0_Q2_shares":51434408.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":997601000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3425000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":21012000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":11087000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":89800000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1248000.0,"OperatingExpenses_2_Q2_USD":106467000.0,"OperatingExpenses_1_Q2_USD":55909000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_2_Q2_USD":1821000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":15459000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.06,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.08,"OtherLiabilitiesNoncurrent_0_Q2_USD":234000.0,"StockholdersEquity_0_Q2_USD":779427000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3772000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":25000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-397526000.0,"MarketableSecurities_0_Q2_USD":0.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":498000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":118000.0,"Ticker":"KOD","CIK":"1468748","name":"KODIAK SCIENCES INC.","OfficialName":"Kodiak Sciences Inc Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"350038530.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]